Rusaine 10 Mg/Ml 10 mg Solution for injection/infusion
PDF Leaflet Revision Date: 06 June 2023
Clinical Summary
Quick overview from the medicine insert
Indication
For increasing blood pressure in adults with hypotension from vasodilation.
Dosage (summary)
Adults: 50-250 mcg IV bolus; 0.5-6 mcg/kg/min continuous infusion.
Onset of Action / Duration
Onset: minutes, Duration: short-lived.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly patients
Pregnancy & Breastfeeding
Caution in pregnancy; safety during lactation not established.
Key Drug Interactions
- MAO inhibitors
- Cardiac glycosides
- Halogenated anesthetics
Contraindications
- Hypersensitivity to phenylephrine
- Severe uncontrolled hypertension
- Severe hyperthyroidism
- Severe heart-block
- Severe cardiac failure
- Severe bradycardia
Common side effects
- Headache
- Bradycardia
- Hypertension
- Extravasation
Counselling Points
- Monitor blood pressure closely
- Dilute before administration
- Avoid extravasation
Serious warnings
- Risk of tissue necrosis with extravasation
- Care in cardiovascular disease
- May precipitate angina
Important Disclaimer
The Rusaine 10 Mg/Ml 10 mg Solution for injection/infusion professional information leaflet below is the property of Lebasi Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
